{
    "clinical_study": {
        "@rank": "163030", 
        "acronym": "U366", 
        "arm_group": [
            {
                "arm_group_label": "Type A Pouch followed by Type B pouch", 
                "arm_group_type": "Experimental", 
                "description": "Enhanced one piece drainable pouch with Type A mouldable adhesive for Stage 1 and 2 followed by pouch with Type B mouldable adhesive for Stage 3"
            }, 
            {
                "arm_group_label": "Type B Pouch followed by Type A pouch", 
                "arm_group_type": "Experimental", 
                "description": "Enhanced one piece drainable pouch with Type B mouldable adhesive for Stage 1 and 2 followed by pouch with Type A mouldable adhesive for Stage 3"
            }
        ], 
        "brief_summary": {
            "textblock": "Certain research and innovation projects require an assessment of the adhesive properties of\n      adhesives, which cannot be established from in-vitro testing. The most valuable data for\n      assessments of this type comes from adhesion and wear time studies involving application to\n      living human skin on volunteers. The purpose of the study is to assess the safety and\n      performance of an enhanced one piece drainable pouch with a mouldable skin barrier wafer in\n      a group of subjects with an ileostomy."
        }, 
        "brief_title": "A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Ileostomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects who provide written informed consent.\n\n          -  Subjects who have an ileostomy and be over 18 years of age.\n\n          -  Subjects who are currently using a one piece drainable pouch.\n\n          -  Subjects who have unbroken peri-stomal skin (healthy normal skin defined as \"normal\n             unbroken skin with certain variations normal for this subject\" to L1 on the SACs\n             Instrument Scale).\n\n          -  Subjects with a stoma considered 'normal' in appearance in accordance with the stoma,\n             colour, moisture and structure rating scales.\n\n          -  Subjects who are willing to attend clinic for a maximum of 5 separate occasions for\n             scheduled visits.\n\n          -  Subjects who are willing to discontinue the use of pastes, adhesive strips and\n             rings/seals used to seal the area between the skin barrier wafer and stoma during the\n             use of the study device.\n\n          -  Subjects who other than their ileostomy  considered to have a healthy/stable health\n             status.\n\n          -  Subjects who have good manual dexterity and be able to take care of their stoma\n             independently, or have a consistent care provider.\n\n          -  Subjects who are willing and able to complete a diary card for the duration of the\n             study.\n\n        Exclusion Criteria:\n\n          -  Subjects with a history of sensitivity to any one of the ostomy products or the\n             components being studied.\n\n          -  Subjects with stoma duration of less than 3 months.\n\n          -  Subjects who currently use a belt with their usual appliance.\n\n          -  Subjects who have been entered into the study before, or who have previously taken\n             part in a study in the last month.\n\n          -  Subjects who require convexity or other skin fillers (pastes, rings, seals) to even\n             undulations of the skin.\n\n          -  Subjects undergoing chemotherapy or radiotherapy.\n\n          -  Subjects who have any other medical condition which, according to the investigator\n             justifies exclusion from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "13", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782196", 
            "org_study_id": "CC-0512-12-U366"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Type A Pouch followed by Type B pouch", 
                    "Type B Pouch followed by Type A pouch"
                ], 
                "intervention_name": "Enhanced one piece drainable pouch with Type A mouldable adhesive", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Type A Pouch followed by Type B pouch", 
                    "Type B Pouch followed by Type A pouch"
                ], 
                "intervention_name": "Enhanced one piece drainable pouch with Type B mouldable adhesive", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 2, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bridgend", 
                        "country": "United Kingdom", 
                        "state": "Mid Glam", 
                        "zip": "CF31 1RQ"
                    }, 
                    "name": "Princess of Wales Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wrexham", 
                        "country": "United Kingdom", 
                        "state": "North Wales", 
                        "zip": "LL13 7TD"
                    }, 
                    "name": "Wrexham Maelor Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taunton", 
                        "country": "United Kingdom", 
                        "state": "Somerset", 
                        "zip": "TA1 5DA"
                    }, 
                    "name": "Musgrove Park Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walsall", 
                        "country": "United Kingdom", 
                        "state": "West Midlands", 
                        "zip": "WS2 9PS"
                    }, 
                    "name": "Manor Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "E9 6SR"
                    }, 
                    "name": "Homerton University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary objective of this study is to evaluate the safety of the enhanced one piece drainable pouch with a mouldable skin barrier wafer and two alternate adhesives in subjects with an ileostomy.", 
            "measure": "Safety - evaluated by the nature and frequency of adverse events including stomal and peristomal skin condition and lesions", 
            "safety_issue": "Yes", 
            "time_frame": "59 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782196"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Performance will be evaluated by comparing the following categories to the subject's usual pouching system\nWear time Adhesion Ease of Use Mouldability Comfort and flexibility Security Skin protection Wafer seal integrity Undermining Filter performance Accessory usage\nAt the end of the study a comparative assessment of the subject's usual pouching system and the study pouch will be made.", 
            "measure": "Performance", 
            "safety_issue": "No", 
            "time_frame": "59 days"
        }, 
        "source": "ConvaTec Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ConvaTec Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "July 2013", 
        "why_stopped": "Leakage"
    }
}